We are live on ! Find out more
PBTH

PROLOR Biotech, Inc. Common Stock
PBTH

Delisted

PBTH was delisted on the 29th of August, 2013.

Back to rankings

3 hedge funds and large institutions have $4.79M invested in PROLOR Biotech, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

89% less capital invested

Capital invested by funds: $44.3M → $4.79M (-$39.5M)

93% less funds holding

Funds holding: 41 → 3 (-38)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 38

Holders
3
Holders Change
-38
Holders Change %
-92.68%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
38
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
+$3.7M

Top Sellers

Rank Fund Capital Flow
1
MMH
Menora Mivtachim Holdings
Israel
-$14.4M
2
GCL
Glazer Capital LLC
New York
-$6.43M
3
AAA
Alpine Associates Advisors
New Jersey
-$5.86M
4
PAM
Panagora Asset Management
Massachusetts
-$4.38M
5
KCM
Kingdon Capital Management
New York
-$2.99M

PBTH Hedge Fund Activity: Q3 2013 in Review

3 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in PROLOR Biotech, Inc. Common Stock (PBTH) for Q3 2013, worth a combined $4.79M — down 89% from $44.3M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of PBTH and 0 opened new positions — a net loss of 38 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Group One Trading, adding an estimated $3.7M. The largest seller was Menora Mivtachim Holdings, exiting entirely with an estimated $14.4M sold.

  • 3 institutional investors held PROLOR Biotech, Inc. Common Stock (PBTH) as of Q3 2013, down from 41 in Q2 2013.
  • Funds reported $4.79M of PROLOR Biotech, Inc. Common Stock stock for Q3 2013, down 89% quarter-over-quarter.
  • 0 funds opened new PROLOR Biotech, Inc. Common Stock positions in Q3 2013 and 38 closed out, a net change of -38 holders.
  • The largest PROLOR Biotech, Inc. Common Stock buyer in Q3 2013 was Group One Trading, an estimated $3.7M added.
  • The largest PROLOR Biotech, Inc. Common Stock seller in Q3 2013 was Menora Mivtachim Holdings, an estimated $14.4M sold.

Based on aggregated 13F filings for Q3 2013.